Cue Biopharma, Inc. (CUE)

Last Closing Price: 4.50 (2026-11-19)

Normalized Income after Taxes (Quarterly)

Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.

Cue Biopharma, Inc. (CUE) had Normalized Income after Taxes of $-50.02M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$0.13M
$-50.02M
--
$0.13M
$47.23M
$-47.10M
$-2.92M
$-50.02M
$-50.02M
$-50.02M
$-50.02M
$-50.02M
Normalized Income after Taxes
$-50.02M
$-47.10M
$-47.06M
10.56M
10.56M
$-4.74
$-4.74
Balance Sheet Financials
$66.71M
$0.23M
$0.55M
$67.25M
$19.73M
--
$9.13M
$28.86M
$38.40M
$38.40M
$38.40M
7.75M
Cash Flow Statement Financials
$-50.03M
$-0.12M
$80.95M
$27.29M
$58.09M
$30.80M
$59.36M
--
--
Fundamental Metrics & Ratios
3.38
--
--
--
--
100.00%
-35679.55%
-35679.55%
--
-37890.91%
-37890.91%
$-50.15M
--
--
--
0.00
--
0.03
3499.09
-130.26%
-130.26%
-74.37%
-130.26%
$4.95
$-4.75
$-4.74